Skip to main content
SpringerLink
Log in

Clinical characteristics related to methotrexate-induced pancytopenia

  • Letters
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hanrahan PS, Scrivens GA, Russell AS. Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 1989; 28: 147–53.

    Google Scholar 

  2. Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis. Arthritis Rheum 1996; 39: 272–6.

    Google Scholar 

  3. Al-Awadhi A, Dale P, McKendry R Jr. Pancytopenia associated with low dose methotrexate therapy: A regional survey. J Rheumatol 1993; 20: 1121–5.

    Google Scholar 

  4. Rheumatoid Arthritis Clinical Trial Archive Group. The effect of age and renal function on the efficacy and toxicity of methotrexate in rheumatoid arthritis. J Rheumatol 1995; 22: 21823.

    Google Scholar 

  5. Maricic M, Davis M, Gall EP. Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprimsul-famethoxazole treatment. Arthritis Rheum 1986; 29: 133–5.

    Google Scholar 

  6. Brown MA, Corrigan AB. Pancytopenia after accidental over-dose of methotrexate. A complication of low-dose therapy for rheumatoid arthritis. Med J Aust 1991; 155; 493–4.

    Google Scholar 

  7. Singh RR, Malaviya AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet 1986; 1: 1390.

    Google Scholar 

  8. MacKinnon SK, Starkebaum G, Willkens RF. Pancytopenia associated with low dose pulse methotrexate in the treatment of rheumatoid arthrits. Semin Arthritis Rheum 1985; 15: 119–26.

    Google Scholar 

  9. Omdal R, Goransson L, Bergrem H. Fatal outcome of low-dose methotrexate therapy in rheumatoid arthritis. Clin Rheumatol 1993; 12: 283–4.

    Google Scholar 

  10. Bruyn GAW, Velthuysen E, Joosten P, Houtman PM. Pancytopenia related eosinophilia in rheumatoid arthritis: A specific methotrexate phenomenon? J Rheumatol 1995; 22: 13716.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Yokohama Shimin Hospital, Yokohama, Kanagawa, Japan

    M. Akizuki

  2. Department of Internal Medicine, Keio University, School of Medicine, 35 Shinanomachi Shinjuku-ku, Tokyo, Japan

    Y. Ohosone MD, Y. Okano, H. Kameda, N. Hama, T. Mimori & Y. Ikeda

Authors
  1. Y. Ohosone MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Okano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Kameda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. N. Hama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T. Mimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Akizuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y. Ikeda
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ohosone, Y., Okano, Y., Kameda, H. et al. Clinical characteristics related to methotrexate-induced pancytopenia. Clin Rheumatol 16, 321–323 (1997). https://doi.org/10.1007/BF02238974

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02238974

Keywords

Search

Navigation